Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1.
Exp Mol Med. 2015 Dec 18;47:e199.
Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2.
Eur J Pharmacol. 2015 Dec 5;768:189-98
Caveolin-1 regulates osteoclast differentiation by suppressing cFms degradation.
Exp Mol Med. 2015 Oct 30;47:e192.
Caveolin-1 regulates osteoclastogenesis and bone metabolism in a sex-dependent manner.
J Biol Chem. 2015 Mar 6;290(10):6522-30.